Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION USP
Report ID | 133451 |
Drug Identification Number | 00884154 |
Brand name | LIDOCAINE HYDROCHLORIDE INJECTION USP |
Common or Proper name | Lidocaine Hydrochloride Injection USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION BLOCK/INFILTRATION |
Packaging size | 25 x 20mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-02-04 |
Estimated end date | |
Actual end date | 2021-09-20 |
Shortage status | Resolved |
Updated date | 2021-09-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.